Celsius Holdings, Inc. sees rising international momentum despite market challenges. Click to discover the U.S. growth ...

UnitedHealth Group's stock has plunged nearly 50% due to the CEO resignation, withdrawal of guidance, and ongoing legal ...

Terex's ESG acquisition diversifies but raises leverage risks. Weak sales, economic uncertainty, and caution on guidance ...

Discover how Porch Group, Inc.'s transition to a fee-based insurance model drives record profitability, 86% gross profit ...

Discover Compass Pathways' journey in developing COMP360 psilocybin for treatment-resistant depression, tackling regulatory ...

Recursion Pharmaceuticals faces a 57% stock drop amid drug setbacks, rising cash burn, and AI discovery doubts. Learn more ...

Bank7 stock soars 41.2% despite mixed data. Discover how strong asset quality & variable rate loans drive growth amid ...

Slow progress, pipeline uncertainty & lack of catalysts weigh despite strong cash. Click to read why KYMR stock is a Hold.

Sanofi (SNY) commits $20B to U.S. research & manufacturing by 2030, boosting R&D & partnerships amidst industry-wide ...

Capital Southwest (CSWC) turned in fiscal Q4 earnings in line with the consensus estimate even as its total investment income ...

Holmlin provided updated full-year 2025 revenue guidance, stating "we expect full year revenues to be in the range of $26 million to $30 million which is an update compared to our previous views on ...

Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...